Skip to main content
. 2022 Apr 29;12(5):656. doi: 10.3390/life12050656

Figure 4.

Figure 4

Change on intensity of pain measured by VAS. Patients allocated to the PBMT-sMF group decreased intensity of pain compared to patients allocated to the placebo PBMT-sMF group (* p < 0.05).